Followers | 3183 |
Posts | 208744 |
Boards Moderated | 2 |
Alias Born | 02/04/2004 |
Wednesday, October 18, 2017 11:26:09 AM
That's the reason for my underlying pessimism because I see nothing over the course of the next calendar year arriving that will cause any institutional accumulation to begin.
Pristiq and Lamictal ANDA's can both be FDA approved and fully commercialized by MNK along with MNK vastly increasing SeroquelXR sales and PAR finally getting around to launching the final remaining 2 FocalinXR strengths...and all that will occur with this stock is maybe regaining all the lost post Rexista AdCom ground and getting back up to $3 per share.
But believe me even if all the above occurs no institutional accumulation wave is gonna occur unless and until IPCI shows big money that they're even remotely capable of unlocking a single shred of value from Rexista, Regabatin, PODRAS or the other 20+ opioid based NDA's said to supposedly be in their behind the scenes pipeline.
The past 2+ years not 1 shred of value has been unlocked from any of the relevant potential valuation driving catalysts that would cause institutional accumulation to begin...and that's a very scary proposition to deeply consider after all these years...because if there was real inherent value associated with Dr. Odidi's science he's either proving to be incapable of unlocking any of it or all the big bio players out there that could partner with IPCI don't believe it or Dr. Odidi hasn't been able to prove it to any of them either from his ego getting in the way or his poor negotiating skills.
There's no logic in watching shareholder value crumble to the point that the NAZ listing itself is now in jeopardy if the science in the NDA pipeline and PODRAS is all we thought it was!
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
- L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - IPCI • PR Newswire (Canada) • 06/08/2023 05:30:00 PM
- Canadian Investment Regulatory Organization Trade Resumption - IPCI • PR Newswire (Canada) • 06/08/2023 05:28:00 PM
- Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results • PR Newswire (Canada) • 06/06/2023 10:00:00 AM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM